July 25, 2025

Rare Pediatric Knee Fractures Reviewed in Depth

Pediatric tibial tubercle fractures continue to present diagnostic and treatment challenges as clinicians navigate variable imaging use, classification systems, and surgical thresholds in the absence of standardized guidelines.

Conexiant

July 15, 2025

Hospital Violence Program Shows No Reinjury Gain

Researchers evaluate the Life Outside of Violence program and find no significant reduction in youth reinjury risk after violent trauma.

Conexiant

July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

April 29, 2025

Foley Catheter Management: New Best Practices, Pitfalls

Foley catheter use is associated with a wide range of complications, from infections to urethral erosion.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

March 21, 2024

A New Approach to Desensitization for Pediatric Kidney Transplant Patients

Pediatric kidney transplantation isn’t a one-and-done endeavor. Unlike adults, whose life expectancy may fall in line with the life of their transplanted kidneys, children and teens typically outlive their transplanted organ—at least the first one.

Cedars-Sinai Pulse

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 23, 2025

Fidaxomicin Effective, Well-Tolerated in Pediatric CDI

A multicenter study of pediatric patients treated with fidaxomicin for C difficile found over half were cured by two weeks, and only one in five had a recurrence within two months.

Conexiant